top of page

Client Reported Outcomes: Parkinson's Disease

Updated: Mar 19

Celltex conducted a registry study based on the reported results of our clients with Parkinson’s disease (PD).


The study utilized a number of survey methods to assess the reported results of clients with PD who received MSC therapy between March 2012 and December 2020.


View this document for a detailed overview of our reported results for PD.


Click above to access this document.
Click above to access this document.


bottom of page